<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="">
    <meta name="author" content="">
    <title>Projet  &raquo; Aide sur des tableurs</title>
    <link href="/static/vendor/bootstrap-3.2.0/css/bootstrap.min.css" media="all" rel="stylesheet" type="text/css" />
    <script src="/static/vendor/jquery/3.2.1/jquery-3.2.1.min.js" type="text/javascript"></script>
    <script src="/static/vendor/bootstrap-3.2.0/js/bootstrap.js" type="text/javascript"></script>
    <script src="/static/vendor/jquery.tablesorter.min.js" type="text/javascript"></script>
    <link href="/static/style.css" media="all" rel="stylesheet" type="text/css" />
</head>
<body>
    <div class="navbar navbar-static-top">
      <div class="navbar-inner">
        <div class="container-fluid header-container">
          <a class="btn btn-navbar" data-toggle="collapse" data-target=".nav-collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <h1 class="brand"><a href="/fr/">Aide sur des tableurs</a>
          </h1>
        </div>
      </div>
    </div>
    
    <nav class="navbar navbar-country" role="navigation">
      <div class="container-fluid">
        <!-- Brand and toggle get grouped for better mobile display -->
        <div class="navbar-header">
          <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1">
            <span class="sr-only">Toggle navigation</span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="/fr/countries/UG/">Ouganda</a>
        </div>

        <!-- Collect the nav links, forms, and other content for toggling -->
        <div class="collapse navbar-collapse" id="bs-example-navbar-collapse-1">
          <ul class="nav navbar-nav">
            <li >
              <a href="/fr/countries/UG/">
                Vue d&#39;ensemble
                <span class="sr-only">(current)</span>
              </a>
            </li>
            <li >
              <a href="/fr/countries/UG/activities/">
                Projets
              </a>
            </li>
            
          </ul>
          <ul class="nav navbar-nav navbar-right">
          <li>
            <a href="/en/countries/UG/activities/SE-0-29-2016-05780_2-285-12182/">EN</a>
          </li>
          <li>
            <a href="/fr/countries/UG/activities/SE-0-29-2016-05780_2-285-12182/">FR</a>
          </li>
          
          </ul>
        </div><!-- /.navbar-collapse -->
      </div><!-- /.container-fluid -->
    </nav>
    

  <div class="container-fluid body-container">
    
      
    
        
<br />


<h2>Utveckling av oral erflornitinbehandling av afrikansk sömnsjuka i sent stadium</h2>

<h2>Development of oral eflornithine for late-stage African sleeping sickness</h2>


<p>Sömnsjuka är en dödlig sjukdom om den ej behandlas med läkemedel. Eflornitin är effektiv vid behandling av sjukdomen i sitt sena, allvarliga stadium. Fler patienter skulle kunna räddas till livet om tillgång fanns till en oralt administrerad behandling, utöver den mycket komplicerade intravenöst givna behandling som används idag. Eflornitin ges som en 50:50-blandning av två stereoisomerer (L- resp D-form). Av dessa är det bara L-eflornitin som utövar effekt. Gruppen har tidigare visat i såväl icke-kliniska som kliniska studier att, till skillnad från intravenösa infusioner, är upptaget av den aktiva L-formen missgynnat efter oral dos. Projektet avser att undersöka eflornitins stereoselektiva absorption för att finna sätt att öka upptaget av L-formen.</p>

<p>Eflornithine is one of only three main-stay drugs registered for the treatment of late-stage human African trypanosomiasis, a uniformly fatal disease if left untreated. Eflornithine is currently recommended as a first line treatment, but due to its complicated intravenous administration, numerous patients are left untreated. A simplified mode of administration would enable more patients having access to treatment. Eflornithine is available as a racemate, a 50:50 mixture of its complementary stereoisomers. L-eflornithine is about 10-20-fold more potent but its absorption after oral dose is less favoured compared with D-eflornithine. The project will explore by non-clinical in vitro, in vivo and pharmacometric methods, a simplified, oral treatment alternative for eflornithine chemotherapy in late-stage T.b. gambiense sleeping sickness by seeking ways to improve the oral absorption of L-eflornithine.</p>

<dl class="dl-horizontal">
  <dt>ID Projet</dt>
  <dd><code>SE-0-29-2016-05780_2-285-12182</code></dd>
  <dt>Statut de l'activité</dt>
  <dd>2 - Implementation</dd>
  <dt>Type d'aide</dt>
  <dd>D02 - Autres formes d’assistance technique</dd>
  <dt>% to Ouganda</dt>
  <dd>100.00</dd>
</dl>

<h2>Organisations</h2>
<dl class="dl-horizontal">
  
  <dt>Funding</dt><dd>Sweden</dd>
  
  <dt>Implementing</dt><dd>Göteborgs universitet</dd>
  
  <dt>Extending</dt><dd>None</dd>
  
</dl>

<div class="modal" id="addSectorsModal" tabindex="-1" role="dialog" aria-labelledby="addSectorsModalLabel" aria-hidden="true">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <button type="button" class="close" data-dismiss="modal"><span aria-hidden="true">&times;</span><span class="sr-only">Close</span></button>
        <h4 class="modal-title">Add Sector</h4>
      </div>
      <div class="modal-body">
        <form class="form-horizontal" role="form">
          <div class="form-group">
            <label for="sector" class="col-sm-2 control-label">Sector</label>
            <div class="col-sm-10">
              <select class="form-control" id="sector-selector" name="sector">
                <option>Select one...</option>
                
              </select>
            </div>
          </div>
          <div class="form-group">
            <label for="sector-percentage" class="col-sm-2 control-label">Percentage</label>
            <div class="col-sm-10">
              <input type="text" class="form-control" id="sector-percentage" placeholder="Percentage">
            </div>
          </div>
        </form>
      </div>
      <div class="modal-footer">
        <button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
        <button type="button" class="btn btn-primary btn-sector-add">Add</button>
      </div>
    </div><!-- /.modal-content -->
  </div><!-- /.modal-dialog -->
</div><!-- /.modal -->


<!--
<div class="pull-right">
  <a class="btn btn-success btn-lg" data-toggle="modal" data-target="#addSectorsModal" href="#addSectorsModal">
    <b>Add sector</b>
  </a>
</div>
-->
<div class="row">
  <div class="col-md-4">
    <h2>Versements par exercice fiscal, trimestre </h2>

    <table class="table" id="sectors">
      <thead>
        <th>Exercice fiscal</th>
        <th>Trimestre fiscal</th>
        <th>Montant (USD)</th>
        <th>Ouganda Montant (USD)</th>
      </thead>
      <tbody>
    
        <tr>
          <td>2018</td>
          <td>Q2</td>
          <td>29,249.91</td>
          <td>29,249.91</td>
        </tr>
    
        <tr>
          <td>2017</td>
          <td>Q2</td>
          <td>39,000.00</td>
          <td>39,000.00</td>
        </tr>
    
      </tbody>
    </table>
  </div>
  <div class="col-md-4">
    <h2>Engagements par exercice fiscal, trimestre </h2>
    <table class="table" id="sectors">
      <thead>
        <th>Exercice fiscal</th>
        <th>Trimestre fiscal</th>
        <th>Montant (USD)</th>
        <th>Ouganda Montant (USD)</th>
      </thead>
      <tbody>
    
        <tr>
          <td>2016</td>
          <td>Q3</td>
          <td>117,000.12</td>
          <td>117,000.12</td>
        </tr>
    
      </tbody>
    </table>
  </div>
  <div class="col-md-4">
    <h2>Projections de CDMT par exercice fiscal </h2>
    <table class="table" id="sectors">
      <thead>
        <th>Exercice fiscal</th>
        <th>Montant (USD)</th>
        <th>Ouganda Montant (USD)</th>
      </thead>
      <tbody>
    
      </tbody>
    </table>
  </div>
</div>

<h2></h2>
<table class="table" id="sectors">
  <thead>
    <th>Code CRS</th>
    <th>%</th>
  </thead>
  <tbody>
    
    <tr id="sector-12182">
      <td>
        Recherche médicale
        (12182)
      </td>
      <td>
        100.0
      </td>
    </tr>
    
  </tbody>
</table>

  </div>
    <script type="text/javascript">
        $('.flashmessage').fadeIn('slow');
    </script>
    <footer class="footer">
    <div class="container">
    <div class="pull-left">
        <p><a href="https://github.com/markbrough/flatiati">Source code on Github</a>, released under the <a href="http://www.gnu.org/licenses/agpl-3.0.html">AGPL v3.0 License</a>.</p>
        <p><a href="http://aidtransparency.net">International Aid Transparency Initiative (IATI)</a></p>
        <p><a href="http://iatiregistry.org">IATI Registry</a> &ndash; <a href="http://iatistandard.org">IATI Standard</a></p>
    </div>
    <div class="pull-right">
        <p><a href="http://twitter.com/mark_brough">@mark_brough</a></p>
    </div>
    </div></footer>
</body>
</html>